Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AZD8701 |
Trade Name | |
Synonyms | AZD-8701|AZD 8701 |
Drug Descriptions |
AZD8701 is an antisense oligonucleotide that targets FOXP3 and modulates expression of its target genes, which potentially results in reduced immunosuppession (Cancer Res 2019;79(13 Suppl):Abstract nr 2713). |
DrugClasses | Antisense Therapy 14 |
CAS Registry Number | NA |
NCIT ID | C178282 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AZD8701 | AZD8701 | 0 | 1 |
AZD8701 + Durvalumab | AZD8701 Durvalumab | 0 | 1 |